Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"University of Manchester" +contributor:("Hyrich, Kimme"). Showing records 1 – 6 of 6 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters

1. Kearsley-Fleet, Lianne Elizabeth. Real-world effectiveness of biologic therapies in children and adults with juvenile idiopathic arthritis in the United Kingdom.

Degree: 2019, University of Manchester

 Biologic therapies have been licenced for use in children and young people with juvenile idiopathic arthritis (JIA) from the early 2000s, with an increasing number… (more)

Subjects/Keywords: JIA; Biologics; Epidemiology; Registers; Rheumatology; Effectiveness; Cohorts

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kearsley-Fleet, L. E. (2019). Real-world effectiveness of biologic therapies in children and adults with juvenile idiopathic arthritis in the United Kingdom. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:320575

Chicago Manual of Style (16th Edition):

Kearsley-Fleet, Lianne Elizabeth. “Real-world effectiveness of biologic therapies in children and adults with juvenile idiopathic arthritis in the United Kingdom.” 2019. Doctoral Dissertation, University of Manchester. Accessed October 20, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:320575.

MLA Handbook (7th Edition):

Kearsley-Fleet, Lianne Elizabeth. “Real-world effectiveness of biologic therapies in children and adults with juvenile idiopathic arthritis in the United Kingdom.” 2019. Web. 20 Oct 2020.

Vancouver:

Kearsley-Fleet LE. Real-world effectiveness of biologic therapies in children and adults with juvenile idiopathic arthritis in the United Kingdom. [Internet] [Doctoral dissertation]. University of Manchester; 2019. [cited 2020 Oct 20]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:320575.

Council of Science Editors:

Kearsley-Fleet LE. Real-world effectiveness of biologic therapies in children and adults with juvenile idiopathic arthritis in the United Kingdom. [Doctoral Dissertation]. University of Manchester; 2019. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:320575

2. Soliman, Moetaza Mahmoud Hassab elsayed. Pharmaco-epidemiological assessment of the clinical use of biologic therapies in the management of rheumatoid arthritis.

Degree: 2012, University of Manchester

 Objectives: The aim of this thesis was to evaluate the clinical use of rituximab (RTX) in rheumatoid arthritis (RA) patients treated in routine clinical practice… (more)

Subjects/Keywords: Rheumatoid arthritis; Rituximab

…197 15 - The University of Manchester - Moetaza Mahmoud Hassab Elsayed Soliman - Doctor… …x28;the “Copyright”) and s/he has given The University of Manchester certain rights to… …and Pharmaceutical Sciences at the University of Manchester. Dedication To my respectful… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Soliman, M. M. H. e. (2012). Pharmaco-epidemiological assessment of the clinical use of biologic therapies in the management of rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:158565

Chicago Manual of Style (16th Edition):

Soliman, Moetaza Mahmoud Hassab elsayed. “Pharmaco-epidemiological assessment of the clinical use of biologic therapies in the management of rheumatoid arthritis.” 2012. Doctoral Dissertation, University of Manchester. Accessed October 20, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:158565.

MLA Handbook (7th Edition):

Soliman, Moetaza Mahmoud Hassab elsayed. “Pharmaco-epidemiological assessment of the clinical use of biologic therapies in the management of rheumatoid arthritis.” 2012. Web. 20 Oct 2020.

Vancouver:

Soliman MMHe. Pharmaco-epidemiological assessment of the clinical use of biologic therapies in the management of rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2012. [cited 2020 Oct 20]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:158565.

Council of Science Editors:

Soliman MMHe. Pharmaco-epidemiological assessment of the clinical use of biologic therapies in the management of rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2012. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:158565


University of Manchester

3. Sampath, Sunil. Developing a Combined Clinical/Genetic Prediction Model for Methotrexate Non-response in Juvenile Idiopathic Arthritis.

Degree: 2019, University of Manchester

 The overall aim of this thesis was to try to predict individuals with Juvenile Idiopathic Arthritis (JIA) who do not respond to a drug called… (more)

Subjects/Keywords: juvenile idiopathic arthritis; methotrexate; response; clinical factors; genetic factors; GWAS; prediction model; JIA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sampath, S. (2019). Developing a Combined Clinical/Genetic Prediction Model for Methotrexate Non-response in Juvenile Idiopathic Arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:318457

Chicago Manual of Style (16th Edition):

Sampath, Sunil. “Developing a Combined Clinical/Genetic Prediction Model for Methotrexate Non-response in Juvenile Idiopathic Arthritis.” 2019. Doctoral Dissertation, University of Manchester. Accessed October 20, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:318457.

MLA Handbook (7th Edition):

Sampath, Sunil. “Developing a Combined Clinical/Genetic Prediction Model for Methotrexate Non-response in Juvenile Idiopathic Arthritis.” 2019. Web. 20 Oct 2020.

Vancouver:

Sampath S. Developing a Combined Clinical/Genetic Prediction Model for Methotrexate Non-response in Juvenile Idiopathic Arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2019. [cited 2020 Oct 20]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:318457.

Council of Science Editors:

Sampath S. Developing a Combined Clinical/Genetic Prediction Model for Methotrexate Non-response in Juvenile Idiopathic Arthritis. [Doctoral Dissertation]. University of Manchester; 2019. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:318457

4. Humphreys, Jennifer. Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies.

Degree: 2015, University of Manchester

 Aim: The aim of this thesis was to validate the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis (RA), in… (more)

Subjects/Keywords: Rheumatoid Arthritis; Epidemiology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Humphreys, J. (2015). Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:269566

Chicago Manual of Style (16th Edition):

Humphreys, Jennifer. “Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies.” 2015. Doctoral Dissertation, University of Manchester. Accessed October 20, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:269566.

MLA Handbook (7th Edition):

Humphreys, Jennifer. “Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies.” 2015. Web. 20 Oct 2020.

Vancouver:

Humphreys J. Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies. [Internet] [Doctoral dissertation]. University of Manchester; 2015. [cited 2020 Oct 20]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:269566.

Council of Science Editors:

Humphreys J. Validation of the 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis with special emphasis on the role of autoantibodies. [Doctoral Dissertation]. University of Manchester; 2015. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:269566

5. Mercer, Louise. Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis.

Degree: 2013, University of Manchester

 AimThe broad aim of this thesis was to explore the risk of malignancy in people with rheumatoid arthritis (RA), treated with anti-tumour necrosis factor (TNF)… (more)

Subjects/Keywords: Rheumatoid arthritis; Anti-TNF; Malignancy

…176 10 Abstract The University of Manchester Louise Kate Mercer Doctor of Philosophy… …Copyright”) and she has given The University of Manchester certain rights to use such… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mercer, L. (2013). Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:185637

Chicago Manual of Style (16th Edition):

Mercer, Louise. “Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis.” 2013. Doctoral Dissertation, University of Manchester. Accessed October 20, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:185637.

MLA Handbook (7th Edition):

Mercer, Louise. “Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis.” 2013. Web. 20 Oct 2020.

Vancouver:

Mercer L. Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Manchester; 2013. [cited 2020 Oct 20]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:185637.

Council of Science Editors:

Mercer L. Safety of long-term anti-TNF use, with respect to malignancy, in a national cohort of people with rheumatoid arthritis. [Doctoral Dissertation]. University of Manchester; 2013. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:185637


University of Manchester

6. Shoop-Worrall, Stephanie Joanna. Can We Predict Remission in Children with Juvenile Idiopathic Arthritis?.

Degree: 2018, University of Manchester

 Background: Long-term consequences of active disease in juvenile idiopathic arthritis (JIA) include persistent pain, disability and potential joint replacement surgery. The aims of treatment are… (more)

Subjects/Keywords: Juvenile idiopathic arthritis; Remission; Epidemiology; Health Outcomes; Paediatric Rheumatology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shoop-Worrall, S. J. (2018). Can We Predict Remission in Children with Juvenile Idiopathic Arthritis?. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317341

Chicago Manual of Style (16th Edition):

Shoop-Worrall, Stephanie Joanna. “Can We Predict Remission in Children with Juvenile Idiopathic Arthritis?.” 2018. Doctoral Dissertation, University of Manchester. Accessed October 20, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317341.

MLA Handbook (7th Edition):

Shoop-Worrall, Stephanie Joanna. “Can We Predict Remission in Children with Juvenile Idiopathic Arthritis?.” 2018. Web. 20 Oct 2020.

Vancouver:

Shoop-Worrall SJ. Can We Predict Remission in Children with Juvenile Idiopathic Arthritis?. [Internet] [Doctoral dissertation]. University of Manchester; 2018. [cited 2020 Oct 20]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317341.

Council of Science Editors:

Shoop-Worrall SJ. Can We Predict Remission in Children with Juvenile Idiopathic Arthritis?. [Doctoral Dissertation]. University of Manchester; 2018. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:317341

.